(Q39654221)

English

Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients

scientific article published on March 2002

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients (English)

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

Guillain–Barré syndrome

0 references

lipopolysaccharide

0 references

0 references

beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->4)-beta-D-Galp-(1->4)-beta-D-Glcp

1 reference

ChEBI release 2020-05-28

beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer

1 reference

ChEBI release 2020-05-28

1 reference

based on heuristic

inferred from title

Campylobacter jejuni

object named as

Campylobacter jejuni

1 reference

based on heuristic

inferred from title

author name string

C W Ang

1

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

J D Laman

2

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

H J Willison

3

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

E R Wagner

4

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

H P Endtz

5

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

M A De Klerk

6

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

A P Tio-Gillen

7

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

N Van den Braak

8

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

B C Jacobs

9

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

P A Van Doorn

10

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

language of work or name

0 references

publication date

1 March 2002

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

Infection and Immunity

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

70

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

3

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

1202-1208

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

Phase variation of a beta-1,3 galactosyltransferase involved in generation of the ganglioside GM1-like lipo-oligosaccharide of Campylobacter jejuni

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127781

14 September 2017

Molecular characterization of Campylobacter jejuni from patients with Guillain-Barré and Miller Fisher syndromes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127781

14 September 2017

The immunopathogenesis of Miller Fisher syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127781

14 September 2017

Rapidly progressive, predominantly motor Guillain-Barré syndrome with anti-GalNAc-GD1a antibodies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127781

14 September 2017

Monoclonal antibodies raised against Guillain-Barré syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127781

14 September 2017

The spectrum of antecedent infections in Guillain-Barre syndrome: A case-control study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127781

14 September 2017

Lipopolysaccharides from Campylobacter jejuni O:41 strains associated with Guillain-Barré syndrome exhibit mimicry of GM1 ganglioside

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127781

14 September 2017

Microtiter assay for detecting Campylobacter spp. and Helicobacter pylori with surface gangliosides which bind cholera toxin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127781

14 September 2017

Lipo-oligosaccharides of Campylobacter jejuni serotype O:10. Structures of core oligosaccharide regions from a bacterial isolate from a patient with the Miller-Fisher syndrome and from the serotype reference strain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127781

14 September 2017

Serum antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in Miller Fisher syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127781

14 September 2017

A somatically mutated human antiganglioside IgM antibody that induces experimental neuropathy in mice is encoded by the variable region heavy chain gene, V1-18.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127781

14 September 2017

A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127781

14 September 2017

Ganglioside-like epitopes of lipopolysaccharides from Campylobacter jejuni (PEN 19) in three isolates from patients with Guillain-Barré syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127781

14 September 2017

Chemical structures of the core region of Campylobacter jejuni O:3 lipopolysaccharide and an associated polysaccharide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127781

14 September 2017

Delineation and comparison of ganglioside-binding epitopes for the toxins of Vibrio cholerae, Escherichia coli, and Clostridium tetani: evidence for overlapping epitopes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127781

14 September 2017

Assessment of current diagnostic criteria for Guillain-Barré syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127781

14 September 2017

Miller-Fisher syndrome associated with Campylobacter jejuni bearing lipopolysaccharide molecules that mimic human ganglioside GD3.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127781

14 September 2017

Lipopolysaccharides from Campylobacter jejuni associated with Guillain-Barré syndrome patients mimic human gangliosides in structure.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127781

14 September 2017

Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain-Barré syndrome and Miller Fisher syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127781

15 June 2018

Structure and conserved characteristics of Campylobacter jejuni lipopolysaccharides

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127781

15 June 2018

Humoral immune response against Campylobacter jejuni lipopolysaccharides in Guillain-Barré and Miller Fisher syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127781

15 June 2018

Cross-reactive antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in patients with Guillain-Barré or Miller Fisher syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127781

15 June 2018

Antibody to GalNAc-GD1a and GalNAc-GM1b in Guillain-Barré syndrome subsequent to Campylobacter jejuni enteritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127781

15 June 2018

Analysis of anti-GM1 ganglioside IgM antibodies cloned from motor neuropathy patients demonstrates diverse V region gene usage with extensive somatic mutation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127781

15 June 2018

Serum anti-GQ1b IgG antibodies recognize surface epitopes on Campylobacter jejuni from patients with Miller Fisher syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127781

15 June 2018

Molecular mimicry between GQ1b ganglioside and lipopolysaccharides of Campylobacter jejuni isolated from patients with Fisher's syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127781

15 June 2018

Campylobacter jejuni lipopolysaccharides in Guillain-Barré syndrome: molecular mimicry and host susceptibility

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127781

17 June 2018

Campylobacter jejuni infection and Guillain-Barré syndrome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127781

21 August 2018

Clinical features and response to treatment in Guillain-Barré syndrome associated with antibodies to GM1b ganglioside

1 reference

https://pubmed.ncbi.nlm.nih.gov/11854201

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ganglioside GM1 mimicry in Campylobacter strains from sporadic infections in the United States

1 reference

https://pubmed.ncbi.nlm.nih.gov/11854201

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/11854201

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential uptake and killing potential of Campylobacter jejuni by human peripheral monocytes/macrophages

1 reference

https://pubmed.ncbi.nlm.nih.gov/11854201

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A case of Guillain-Barré syndrome following a family outbreak of Campylobacter jejuni enteritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/11854201

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-GQ1b IgG antibody is associated with ataxia as well as ophthalmoplegia

1 reference

https://pubmed.ncbi.nlm.nih.gov/11854201

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Campylobacter jejuni gene associated with immune-mediated neuropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/11854201

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human serum antibody response in Campylobacter jejuni enteritis as measured by enzyme-linked immunosorbent assay

1 reference

https://pubmed.ncbi.nlm.nih.gov/11854201

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cloning of human anti-GM1 antibodies from motor neuropathy patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/11854201

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/IAI.70.3.1202-1208.2002

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39654221&oldid=2080958540"